<DOC>
	<DOCNO>NCT00229619</DOCNO>
	<brief_summary>This study test whether immune-suppressing drug rituximab increase blood count reduce need transfusion patient moderate aplastic anemia , pure red cell aplasia , Diamond Blackfan anemia . These rare serious blood disorder immune system turn bone marrow cell , cause bone marrow stop produce red blood cell patient pure red cell aplasia Diamond Blackfan anemia , red blood cell , white blood cell platelets patient aplastic anemia . Rituximab laboratory-made monoclonal antibody recognize destroy white blood cell call lymphocytes responsible destroy bone marrow cell diseases . The drug currently approve Food Drug Administration treat patient B-cell non-Hodgkin lymphoma , disease white blood cell .</brief_summary>
	<brief_title>Rituximab Treat Moderate Aplastic Anemia , Pure Red Cell Aplasia , Diamond Blackfan Anemia</brief_title>
	<detailed_description>This study test whether immune-suppressing drug rituximab increase blood count reduce need transfusion patient moderate aplastic anemia , pure red cell aplasia , Diamond Blackfan anemia . These rare serious blood disorder immune system turn bone marrow cell , cause bone marrow stop produce red blood cell patient pure red cell aplasia Diamond Blackfan anemia , red blood cell , white blood cell platelets patient aplastic anemia . Rituximab laboratory-made monoclonal antibody recognize destroy white blood cell call lymphocytes responsible destroy bone marrow cell diseases . The drug currently approve Food Drug Administration treat patient B-cell non-Hodgkin lymphoma , disease white blood cell . Participants receive four dos rituximab , week 4 week needle arm vein . The infusion rate depend well patient tolerates drug . The first infusion usually take 4 6 hour rest take 3 4 hour . The first fourth infusion give NIH ; second third may give NIH patient 's refer doctor . Patients respond rituximab relapse may receive one additional course four dos . Patients may continue transfusion current medication , include growth factor ( e.g. , Epogen Neupogen ) study , may stop take immunosuppressive drug , prednisone cyclosporine . Patients must start another immunosuppressive medication take rituximab follow safety clinic visit one week month 6 month first dose rituximab . Patients blood test week receive rituximab evaluate blood count . After treatment complete , patient evaluate month 6 month , year 3 year monitor response treatment drug side effect . Patients evaluate NIH 3- 6-month visit annual visit . They may see NIH refer doctor 1- , 2- , 4- 5-month visit . A blood test do every visit , bone marrow aspiration biopsy do 3-month visit ( clinically need evaluate effect rituximab bone marrow cell ) .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Anemia , Diamond-Blackfan</mesh_term>
	<mesh_term>Red-Cell Aplasia , Pure</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>INCLUSION CRITERIA : Diagnosis acquire moderate aplastic anemia define aplastic anemia ( hypocellular bone marrow ) evidence underlie disease process depression least two three blood count value : Absolute neutrophil count ( ANC ) equal less l200/mm ( 3 ) platelet count equal le 70,000/mm ( 3 ) anemia hemoglobin equal less 8.5 g/dl absolute reticulocyte count equal le 60,000/mm ( 3 ) transfusiondependent patient fulfil criterion severe disease define bone marrow cellularity le 30 % ( exclude lymphocyte ) depression least two three peripheral count : ANC equal less 500/ul platelet count equal le 20,000/ul reticulocyte count le 60,000/ul Or Diagnosis pure red cell aplasia Diamond Blackfan anemia require red blood cell ( RBC ) transfusion Pure red cell aplasia define anemia , reticulocytopenia ( reticulocyte count equal le 50,000/ mm ( 3 ) ) absent decrease marrow erythroid precursor Diamond Blackfan anemia define anemia , reticulocytopenia ( reticulocyte count equal le 50,000/ mm ( 3 ) ) absent decrease marrow erythroid precursor diagnose early age Because population prone dry bone marrow aspirate , subject sufficient bone marrow collect evaluation cellularity exclude provided meet inclusion criterion base peripheral blood count . Pure Red cell Aplasia Diamond Blackfan patient must age great equal 2 year old weight great 12 kg ; Moderate Aplastic anemia patient must age great equal 18 . Refractory least 1 course immunosuppressive therapy relapse disease prior immunosuppressive therapy ( PRCA/DBA patient ) . Patients parent ( ) /responsible guardian ( ) must able comprehend willing sign inform consent . EXCLUSION CRITERIA : Current diagnosis Fanconi 's anemia congenital bone marrow failure syndromes except DBA History cytogenetic abnormality indicate myelodysplasia ( MDS ) Active infection adequately respond appropriate therapy HIV positivity Positive anti hepatitis B core antibody ( antiHBc ) HBsAG History clinically significant arrhythmia Known anaphylaxis immunoglobulin E ( IgE ) mediate hypersensitivity murine proteins component product . Moribund status concurrent hepatic , renal , cardiac , neurologic , pulmonary , infectious , metabolic disease severity would preclude patient 's ability tolerate protocol therapy , death within next month likely Potential subject cancer active chemotherapeutic treatment take drug hematological effect eligible . History recent ongoing B19 parvovirus infection Psychiatric , affective , disorder may compromise ability give informed consent cooperate research study . Pregnancy lactation unwillingness take contraceptive Participation investigational drug trial exposure investigational agent ( hematopoietic growth factor ) within 30 day study entry . Use low dose immunosuppressive agent may continue PIs discretion provide patient take drug least 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>rituxan</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Bone Marrow Failure</keyword>
	<keyword>Monoclonal Antibody Therapy</keyword>
	<keyword>Diamond Blackfan Anemia ( DBA )</keyword>
	<keyword>T -Cells</keyword>
	<keyword>B-Cells</keyword>
	<keyword>Hematopoiesis</keyword>
	<keyword>Moderate Aplastic Anemia ( MAA )</keyword>
	<keyword>Diamond-Blackfan Anemia</keyword>
	<keyword>DBA</keyword>
	<keyword>Pure Red Cell Aplasia</keyword>
	<keyword>PRCA</keyword>
</DOC>